The store will not work correctly when cookies are disabled.
(E)-1-(5-butylpyrazin-2-yl)-3-(2-hydroxyphenyl)prop-2-en-1-one
ID: ALA2288843
PubChem CID: 6474712
Max Phase: Preclinical
Molecular Formula: C17H18N2O2
Molecular Weight: 282.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCc1cnc(C(=O)/C=C/c2ccccc2O)cn1
Standard InChI: InChI=1S/C17H18N2O2/c1-2-3-7-14-11-19-15(12-18-14)17(21)10-9-13-6-4-5-8-16(13)20/h4-6,8-12,20H,2-3,7H2,1H3/b10-9+
Standard InChI Key: IXODMMTUVWZWER-MDZDMXLPSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
26.8916 -6.4838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8905 -7.3034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5985 -7.7123 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3082 -7.3029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3053 -6.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5967 -6.0750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0115 -6.0690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7207 -6.4749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0084 -5.2518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.4269 -6.0636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1361 -6.4696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1361 -7.2856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8445 -7.6915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5517 -7.2802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5460 -6.4588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8370 -6.0566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1824 -7.7114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1818 -8.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4738 -8.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7664 -8.5275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8303 -5.2395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
16 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.34 | Molecular Weight (Monoisotopic): 282.1368 | AlogP: 3.42 | #Rotatable Bonds: 6 |
Polar Surface Area: 63.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.85 | CX Basic pKa: 0.02 | CX LogP: 3.26 | CX LogD: 3.24 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.65 | Np Likeness Score: -0.16 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |